Filter by Interests
Manufacturing Quality Control for Plasmid DNA Critical Starting Materials
Andrew Frazer, Lauren R. Salvitti
29 April 2025
Register
Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing
K Bruce, K Bharti, I Barbaric et al
23 April 2025
Register
Strategies for streamlined manufacturing and analytics in CGT development
Laura Mueller, Silvio Weber, Dirk Windgassen
01 April 2025
Register
Producing MSC-derived cell therapies: workflows, technologies, and case studies
I Malaspina, S Mei, T Ting et al
28 March 2025
Expert Roundtable
Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells
Mindy Miller, Nathan Frank
27 March 2025
Watch
Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes
Marc Struhalla, Svenja Michalek
26 March 2025
Innovator Insight
Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success
Peter Szaraz, Tessel Hammink
20 March 2025
Watch
Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings
Kasey Kime, Xiao Peng
20 March 2025
Innovator Insight
Streamlining the supply chain: insights on raw material sourcing and quality by design
Lara Silverman
19 March 2025
Interview
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing
Lili Belcastro, Basak Clements, Claire Wartel
18 March 2025
Watch
Driving innovation to advance allogeneic cell therapies through manufacturing platform development
Jason Dowd
18 March 2025
Interview
Next-gen immunotherapy: a guide for CGT developers
Alex Sargent
11 March 2025
Watch
Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing
Laura Koivusalo, Anni Mörö, Ross Macdonald
11 March 2025
Commentary
Enabling allogeneic cell therapy development: scaling up generation of PSC-derived NK cells
Mark Kennedy, Marcus Bunn
10 March 2025
Innovator Insight
Next-gen cell therapy manufacturing: leveraging flexibility and automation for success
Fred Parietti, David Shaw, Carl Dargitz
06 March 2025
Watch
Raw and starting materials for cellular and gene therapy products
Gary du Moulin
04 March 2025
Review
Worth the switch? Enhancing process performance for cell therapy manufacturing with an animal component-free raw material strategy
Phil Morton, Shanya Jiang
03 March 2025
Innovator Insight
Developing autologous iPSC-based therapies for Parkinson’s disease treatment
Kim Raineri
28 February 2025
Interview
Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors
J Hengst, Q Rafiq, R Ladi et al
27 February 2025
Innovator Insight
Robotic gloveless isolator technology enhances regional production of advanced therapeutics
Zach Hartman, Peter Boman
27 February 2025
Innovator Insight
Avoiding scale-up pitfalls: upstream process development strategies for AAV manufacturing
Sandy Tseng, Hugh Murray
26 February 2025
Watch